Search

everythinglearnresearchcommunity

for

Search:↓

Dimethyl-fumarate may cause temporary hair loss.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Nail loss may be a side effect of the MS drug teriflunomide.

MS treatments can cause significant hair loss, affecting mental health.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Glycerol may improve wound healing and prevent keloids, a device can measure itch intensity, male pattern baldness is highly heritable, and fumaric acid esters may work for psoriasis by causing cell death in T cells.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Methotrexate may help stabilize frontal fibrosing alopecia.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A woman with lupus developed rare skin growths that went away on their own.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.